However, we herein demonstrated for the first time that, through its ability to inhibit JNK, which is required for the maintenance of cancer stem cells, CEP-1347 is capable of targeting cancer stem cells both in vitro and in vivo [24]. The gene discussed is MAPK8; the disease is cancer.